M, A., E, A., C, C., M, B., C, Y., & SH, R. (2024). Bevacizumab for Retinopathy of Prematurity Is Not Associated With Systemic Hypertension. Journal of pediatric ophthalmology and strabismus, 61(6), 434. https://doi.org/10.3928/01913913-20240620-02
Chicago Style (17th ed.) CitationM, Akbar, Avdagic E, Carlos C, Blair M, Yang C, and Rodriguez SH. "Bevacizumab for Retinopathy of Prematurity Is Not Associated With Systemic Hypertension." Journal of Pediatric Ophthalmology and Strabismus 61, no. 6 (2024): 434. https://doi.org/10.3928/01913913-20240620-02.
MLA (9th ed.) CitationM, Akbar, et al. "Bevacizumab for Retinopathy of Prematurity Is Not Associated With Systemic Hypertension." Journal of Pediatric Ophthalmology and Strabismus, vol. 61, no. 6, 2024, p. 434, https://doi.org/10.3928/01913913-20240620-02.